首页> 外国专利> The use of non steroidal anti-inflammatory compounds for preparing Medicines,Non steroidal compounds which are suitable for this job and lospreparados Pharmaceuticals containing these compounds

The use of non steroidal anti-inflammatory compounds for preparing Medicines,Non steroidal compounds which are suitable for this job and lospreparados Pharmaceuticals containing these compounds

机译:非甾体类抗炎化合物在制备药物中的用途,适合该工作的非甾体类化合物以及含有这些化合物的lospreparados Pharmaceuticals

摘要

A drug with an anti-inflammatory effect is prepared using non steroidal compounds in response to a common formula (1), wherein R1 and R2 are the same or different, representing a hydrogen atom, a tar group 1-5, or together with a C atom in the chain, R3 represents a group of C1-5 partially or completely fluorinated tar; a represents a group of formula (6), where (dotted line refers to ligation),R4 represents a hydrogen atom, a C1-5 tar group, a C1-10 ACIO group, a c3-10 massive skeleton, a c2-5 cyanopropyl compound, a substituted or substituted alilo c3-10 group, a substituted or abandoned propylene c3-10 group, an ungrupo alcoxicologio c2-5, A group of C1-5 tar is partially or completely replaced by fluorinated atoms; r5-r8 is the same or different, and is selected as a group composed of hydrogen atoms, halogenated atoms and alcoxi C1-5, R4 and R5. Together, it also represents an overall aperiodic queen ring with 5-7 members. OxygenIt may eventually contain at least another heteroatom composed of oxygen, nitro and sulfur; B represents a carbon group or a CH2 group; and AR represents a ring system selected from some recipe groups (2) to (5).where the residues X3a, X3b, X4, X6, X7 (in the partial formulas (2) and (3)) and Y4, Y5, Y7, Y8 (in the partial formulas (4) and (5)) are equal or different and are chosen from hydrogen atoms, C1-5 allyl groups, partially or fully fluorinated C1-5 alkyl groups, and furthermore residues X4, X6, X7 (of the partial formulas (2) and (3)) or the residues Y5, Y7, Y8 (in the partial formulas (4) and (5)) are chosen from halogen atoms, hydroxyl groups, C1-5 alkoxy groups or C1-5 alkanoyloxy groups, and, for the case in that B represents a CH2 group, physiologically acceptable salts are also used,The general formula compound (1) is formed by the total amount of acid. Of pharmaceutical preparations
机译:响应于通式(1),使用非甾体化合物制备具有抗炎作用的药物,其中R1和R2相同或不同,代表氢原子,1-5位焦油基团或与链中的C原子,R3代表部​​分或完全氟化的焦油的C1-5基团; a表示式(6)的基团,其中(虚线是指连接),R4表示氢原子,C1-5的焦油基团,C1-10的ACIO基团,c3-10的大骨架,c2-5氰基丙基化合物,取代或取代的alilo c3-10基团,取代或废弃的丙烯c3-10基团,无醇铝氧环氧化物c2-5,C1-5焦油基团被氟化原子部分或完全取代; r5-r8相同或不同,并且选自氢原子,卤原子和醇C1-5,R4和R5。在一起,它还代表了具有5-7个成员的整体非周期性女王戒指。 OxygenIt最终可能至少包含另一个由氧,硝基和硫组成的杂原子; B表示碳基或CH 2基; AR代表选自某些配方组(2)至(5)的环系统,其中残基X3a,X3b,X4,X6,X7(在部分公式(2)和(3)中)和Y4,Y5,Y7 ,Y 8(在部分式(4)和(5)中)相同或不同,并且选自氢原子,C 1-5烯丙基,部分或完全氟化的C 1-5烷基,以及残基X4,X6,X7 (在部分式(2)和(3)中)或残基Y5,Y7,Y8(在部分式(4)和(5)中)选自卤素原子,羟基,C1-5烷氧基或C1 -5个烷酰氧基,在B表示CH 2基的情况下,还使用生理上可接受的盐,通式(1)的化合物由酸的总量形成。药物制剂

著录项

  • 公开/公告号AR021419A1

    专利类型

  • 公开/公告日2002-07-17

    原文格式PDF

  • 申请/专利权人 SCHERING AKTIENGESELLSCHAFT;

    申请/专利号AR1999P106045

  • 发明设计人

    申请日1999-11-26

  • 分类号C07D307/88;C07D265/02;A61K31/192;A61K31/343;A61K31/535;A61P29/00;

  • 国家 AR

  • 入库时间 2022-08-22 00:46:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号